Dolby Laboratories, Inc. Financials

Market Capitalization $7.26 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	28.62
Forward PE	19.83
Price to Sales TTM	$5.50
Price to Book MRQ	$2.82
Enterprise to Revenue	4.97
Enterprise to EBITDA	17.89

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-09-27
Most Recent Quarter	2025-03-31
Profit Margin	19.44%
Operating Margin	30.30%
Return on Assets TTM	5.64%
Return on Equity TTM	10.31%

Income Statement

Revenue TTM	$1,320,184,064
Revenue per Share TTM	$13.79
Quarterly Revenue Growth	1.40%
Gross Profit TTM	$1,173,913,984
EBITDA	$390,422,000
Net Income to Common TTM	$256,628,992
Diluted EPS TTM	$2.64
Quarterly Earnings Growth YoY	-6.20%

Balance Sheet

Total Cash MRQ	$626,550,976
Total Cash per Share MRQ	$6.52
Total Debt MRQ	$
Total Debt to Equity MRQ	1.57
Current Ratio MRQ	3.04
Book Value per Share MRQ	$26.79

Cash Flow

Operating Cash Flow TTM	$419,110,016
Levered Free Cash Flow TTM	$350,792,256

DLB Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	95,393,221
Float Shares	60,552,440
Avg 10 Volume	440,110
Avg 30 Volume	None
Shares Short	1,232,378
Short Ratio	3.76
Short % of Shares	3.00%
% Held by Insiders	1.36%
% Held by Institutions	95.65%

Stock Price Summary

Beta	0.92
Fifty Two Week Low	$66.35
Fifty Two Week High	$89.66
Fifty Two Week Change	-5.65%
Day 50 MA	$75.22
Day 200 MA	$77.26

Dividends and Splits

Forward Annual Dividend Rate	$1.32
Forward Annual Dividend Yield	1.75%
Trailing Annual Dividend Rate	$1.26
Trailing Annual Dividend Yield	1.67%
Payout Ratio	47.73%
Dividend Date	2025-05-21
Ex Dividend Date	2025-05-13
Last Split Factor
Last Split Date